Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam for Splanchnic Perfusion in CPB
NCT00747331Phase 4Completed
- Sponsor
- Policlinico San Donato
- Start
- Sep 2008
- Primary completion
- Apr 2009
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenoldopam in splanchnic hypoperfusion, sponsored by Policlinico San Donato. Started Sep 2008; status: completed.
02
Drugs
fenoldopam
03
Conditions
splanchnic hypoperfusion
Beyond the preview
Go deeper on NCT00747331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747331.